Back to Results
First PageMeta Content
Organofluorides / Aging-associated diseases / Medical emergencies / Cyclopropanes / Eli Lilly and Company / Prasugrel / Clopidogrel / Ticagrelor / Myocardial infarction / Chemistry / Organic chemistry / Medicine


NDA[removed]Brilinta® (ticagrelor) Efficacy Review Cardio-Renal Advisory Committee Meeting July 28, 2010 Robert P. Fiorentino, MD, MPH CDER, DCRP
Add to Reading List

Open Document

File Size: 1,11 MB

Share Result on Facebook

Company

ACS / /

Continent

North America / /

Country

United States / /

IndustryTerm

clinical management / /

MarketIndex

ACS / /

MedicalCondition

non ST elevation myocardial infarction / stent thrombosis / strokes / ST elevation myocardial infarction / stroke / nonfatal stroke / /

Organization

Efficacy Review Cardio-Renal Advisory Committee / /

Person

Robert P. Fiorentino / /

Product

clopidogrel / /

ProvinceOrState

Michigan / /

SocialTag